V. Bryan Lawlis is Director at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 24 open-market trades across 2 companies since 2012, most recently 2025-05-09.
CIK 0001247681
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2025, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GERN | BUY | 2025-05-09 | 2025-05-13 | $1.18 | $16K | +14.2% | +22.8% | +7.1% |
| GERN | SELL · 10b5-1 | 2024-05-15 | 2024-05-17 | $3.75 | $131K | -9.4% | +21.9% | +16.4% |
| GERN | SELL · 10b5-1 | 2023-05-11 | 2023-05-11 | $3.00 | $105K | +4.1% | +14.9% | +2.4% |
| BMRN | SELL · 10b5-1 | 2023-04-03 | 2023-04-04 | $97.09 | $825K | +4.5% | -0.6% | -10.5% |
| BMRN | SELL | 2022-04-14 | 2022-04-18 | $83.66 | $356K | +1.3% | -4.2% | +4.8% |
| BMRN | SELL | 2022-01-14 | 2022-01-19 | $87.61 | $745K | +2.8% | -1.5% | -6.5% |
| BMRN | SELL | 2021-04-15 | 2021-04-19 | $76.90 | $577K | +0.8% | -3.9% | -0.9% |
| BMRN | SELL | 2021-02-16 | 2021-02-18 | $87.41 | $656K | -6.8% | -6.1% | -8.6% |
| BMRN | SELL | 2020-06-05 | 2020-06-09 | $107.46 | $952K | +15.4% | +17.9% | -30.7% |
| BMRN | SELL | 2020-03-16 | 2020-03-18 | $76.01 | $1.3M | +14.7% | +24.0% | +48.1% |
| BMRN | SELL | 2019-12-17 | 2019-12-19 | $83.36 | $313K | -1.7% | +2.5% | -15.3% |
| BMRN | SELL | 2019-09-17 | 2019-09-18 | $74.47 | $559K | -10.5% | -8.2% | +10.7% |
| BMRN | SELL | 2019-06-17 | 2019-06-19 | $81.08 | $304K | -2.0% | -5.0% | -12.7% |
| BMRN | SELL | 2019-03-27 | 2019-03-29 | $89.76 | $193K | +3.7% | -3.7% | -5.6% |
| BMRN | SELL | 2018-12-27 | 2018-12-28 | $82.53 | $355K | +12.0% | +11.1% | +4.7% |
| BMRN | SELL | 2018-09-27 | 2018-09-28 | $97.93 | $421K | +0.3% | -4.5% | -14.4% |
| BMRN | SELL | 2018-06-27 | 2018-06-29 | $93.52 | $201K | +10.6% | +6.4% | +4.9% |
| BMRN | SELL | 2018-04-17 | 2018-04-19 | $85.00 | $319K | +3.1% | +7.0% | +22.9% |
| BMRN | SELL | 2018-01-02 | 2018-01-04 | $88.84 | $333K | -1.7% | -4.1% | -13.2% |
| BMRN | SELL | 2017-09-15 | 2017-09-19 | $91.26 | $342K | +1.0% | -4.3% | +0.5% |
| BMRN | SELL | 2017-06-16 | 2017-06-20 | $90.00 | $338K | -2.0% | -5.4% | -0.8% |
| BMRN | SELL | 2017-03-01 | 2017-03-02 | $95.00 | $713K | -1.7% | -7.1% | -6.0% |
| BMRN | SELL | 2016-11-09 | 2016-11-14 | $95.00 | $713K | -3.2% | -6.9% | -1.1% |
| BMRN | SELL | 2016-07-27 | 2016-07-28 | $95.39 | $105K | -3.1% | -2.5% | -16.7% |
| BMRN | SELL | 2016-07-22 | 2016-07-26 | $95.01 | $608K | +8.0% | +3.7% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.